Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$18.38 USD
+0.13 (0.71%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $18.39 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FMS 18.38 +0.13(0.71%)
Will FMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FMS
Fresenius Medical (FMS) Q2 Earnings In Line, Operating Margin Up
Can These 3 Medical Device Stocks Hit Earnings This Season?
FMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Here's Why Fresenius (FMS) is a Strong Value Stock
Other News for FMS
Jefferies Keeps Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan
GLOBAL BROKER RATINGS: Citi says 'buy' Glencore; Deutsche cuts Evotec
European exporters with stretched valuations - JPM
GLOBAL BROKER RATINGS: LBBW raises BASF; Goldman Sachs cuts Heidelberg